Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
NAV2024-12-19 | Chg.+1.1700 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
343.6800EUR | +0.34% | reinvestment | Equity | Candriam ▶ |
Name | ISIN | Performance | Volatility | Sharpe ratio | ||
---|---|---|---|---|---|---|
1. | Janus Henderson Horizon Biotechnology Fund IU2 EUR | LU2441282626 | +19.16% | 20.77% | 0.79 | |
2. | Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | IE00B3WVRB16 | +18.71% | 20.63% | 0.77 | |
3. | Janus Henderson Horizon Biotechnology Fund A2 EUR | LU2441282899 | +18.84% | 20.99% | 0.76 | |
4. | Candriam Equities L Biotech.R EUR Acc | LU1269736838 | +13.47% | 18.21% | 0.58 | |
5. | Candriam Equities L Biotech.I EUR Acc | LU1120766032 | +12.57% | 18.04% | 0.54 | |
6. | Candriam Equities L Biotech.C EUR | LU1120766388 | +12.43% | 18.20% | 0.53 | |
7. | J.Henderson H.BioTech.F.IU2 | LU1897414568 | +13.75% | 21.50% | 0.51 | |
8. | J.Henderson H.BioTech.F.H2 | LU1897414485 | +13.63% | 21.49% | 0.50 | |
9. | J.Henderson H.BioTech.F.A2 | LU1897414303 | +13.05% | 21.51% | 0.47 | |
10. | Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating | LU1725387622 | +7.87% | 10.66% | 0.47 |
Performance | Volatility | Sharpe ratio |
---|---|---|